Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Lymphoid 1

Conditions

Neuroblastoma 3Glioma 2Glioblastoma 2Brain Neoplasms 2Recurrence 1Oligodendroglioma 1Neoplasms 1Lymphoma, Follicular 1Astrocytoma 1

Interventions

Temozolomide 405Radiotherapy 202Bevacizumab 157Radiation 80Magnetic Resonance Spectroscopy 77Lomustine 49Surgical Procedures, Operative 45Carmustine 41pembrolizumab 40Irinotecan 38Nivolumab 32Specimen Handling 28Carboplatin 27Radiosurgery 24Erlotinib Hydrochloride 24Drug Therapy 23Chemotherapy, Adjuvant 23Radiotherapy, Intensity-Modulated 22Cyclophosphamide 20Aminolevulinic Acid 20O(6)-benzylguanine 17sargramostim 16Radiotherapy, Conformal 15Blood Specimen Collection 15temsirolimus 14Granulocyte-Macrophage Colony-Stimulating Factor 14Everolimus 14Vorinostat 13Sorafenib 13Ipilimumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioblastoma × Ketoconazole × CNS × Clear all
NCT07585851 2026-05-14

Administration of Repurposed Ketoconazole in Glioma Patients

Universitas Padjadjaran

Phase EARLY_PHASE1 Active not recruiting
80 enrolled
CNSLymphoid

Glioblastoma, Lymphoma, Follicular

NCT04869449 2026-01-07

Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas

Milton S. Hershey Medical Center

Phase EARLY_PHASE1 Terminated
1 enrolled
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡